Wilbanks Smith & Thomas Asset Management LLC Bridge Bio Pharma, Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

  • $3.54 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
SELL
$13.29 - $18.01 $19,881 - $26,942
-1,496 Reduced 5.95%
23,641 $406,000
Q3 2022

Oct 31, 2022
BUY
$7.94 - $12.36 $325 - $506
41 Added 0.16%
25,137 $250,000
Q1 2022

May 05, 2022
BUY
$7.34 - $17.16 $184,204 - $430,647
25,096 New
25,096 $209,000
Q4 2021

Feb 08, 2022
SELL
$11.38 - $53.41 $64,888 - $304,543
-5,702 Closed
0 $0
Q3 2021

Nov 04, 2021
BUY
$46.87 - $64.24 $267,252 - $366,296
5,702 New
5,702 $267,000

Others Institutions Holding BBIO

# of Institutions
291
Shares Held
171M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.45B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email